60 Degrees Pharma Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.61

-0.22 (-12.02%)

As of Mar 24, 6:11 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +65.2% upside

Low Target $2.13

Average Target $2.66

High Target $3.16

Current Price $1.61

Current
$1.61

Target
$2.66

$2.13 $2.66 avg $3.16

Scenario Analysis

Bear Case

$2.13

32.3%

Low target

Base Case

$2.66

+65.2%

Avg target

Bull Case

$3.16

+96.3%

High target

Risk/Reward

3.0x

Favorable

Price in Context

52-Week High

$17.68

-90.9% from high

52-Week Low

$1.36

+18.4% from low

Target vs 52W High

$2.66

-85.0% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%